AI
AF Expert Advisor
NICE NG196 · Powered by Claude
Ask a clinical question or choose a scenario:
For clinical decision support only. Always apply clinical judgement.
Quick Reference
CHA₂DS₂-VASc ≥2Offer DOAC (Rec 1.6.3)
CHA₂DS₂-VASc 1 (M)Consider DOAC (Rec 1.6.4)
TTR <65%Reassess anticoagulation (Rec 1.6.11)
Onset <48hRate or rhythm control (Rec 1.8.2)
Onset >48hRate control + 3wk OAC pre-DCCV
HF + AFNo CCBs (Rec 1.7.3 & 1.8.3)
Structural HD + rhythm RxAmiodarone only (Rec 1.7.13)
Post-ablationAntiarrhythmic 3 months (Rec 1.7.22)
DOAC Options (Rec 1.6.9)
ApixabanTA275
DabigatranTA249
EdoxabanTA355
RivaroxabanTA256
Use in line with individual NICE TA criteria. Check renal function and dose adjustments.
⚠ Key Prohibitions
- ✗ Aspirin monotherapy for stroke prevention
- ✗ Amiodarone for long-term rate control
- ✗ Class 1c drugs in ischaemic/structural HD
- ✗ CCBs in HFrEF or decompensated HF
- ✗ Stop OAC solely because AF no longer detected
- ✗ LAAO as alternative to OAC if OAC tolerated
- ✗ Routine TTE solely for stroke risk if OAC agreed
- ✗ Statins started de novo to prevent post-op AF